loading
전일 마감가:
$44.65
열려 있는:
$45.17
하루 거래량:
65,773
Relative Volume:
0.15
시가총액:
$2.26B
수익:
$379.25M
순이익/손실:
$-77.34M
주가수익비율:
-28.33
EPS:
-1.6122
순현금흐름:
$-27.87M
1주 성능:
+2.62%
1개월 성능:
+11.28%
6개월 성능:
+2.14%
1년 성능:
+82.79%
1일 변동 폭
Value
$45.17
$45.74
1주일 범위
Value
$43.50
$46.57
52주 변동 폭
Value
$24.07
$54.23

Mirum Pharmaceuticals Inc Stock (MIRM) Company Profile

Name
명칭
Mirum Pharmaceuticals Inc
Name
전화
650-667-4085
Name
주소
989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY
Name
직원
334
Name
트위터
@mirumpharma
Name
다음 수익 날짜
2024-11-04
Name
최신 SEC 제출 서류
Name
MIRM's Discussions on Twitter

MIRM을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
MIRM
Mirum Pharmaceuticals Inc
45.71 2.18B 379.25M -77.34M -27.87M -1.6122
Biotechnology icon
ONC
Beone Medicines Ltd Adr
256.74 26.69B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
448.02 114.81B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.2213 41.83M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
83.49 6.60B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
498.49 65.36B 14.09B 4.50B 2.96B 39.28

Mirum Pharmaceuticals Inc Stock (MIRM) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-05-19 재개 H.C. Wainwright Buy
2024-04-17 개시 Stifel Buy
2023-12-18 재확인 H.C. Wainwright Buy
2023-11-20 재개 JP Morgan Overweight
2023-11-13 개시 Morgan Stanley Overweight
2023-10-24 개시 Cantor Fitzgerald Overweight
2023-10-17 재개 Evercore ISI Outperform
2023-09-20 개시 JMP Securities Mkt Outperform
2022-09-01 개시 Citigroup Buy
2021-09-20 개시 JP Morgan Overweight
2020-08-07 업그레이드 Raymond James Outperform → Strong Buy
2020-08-03 개시 H.C. Wainwright Buy
2020-07-31 개시 Piper Sandler Overweight
2020-06-25 개시 Robert W. Baird Outperform
2019-08-12 개시 Citigroup Buy
2019-08-12 개시 Evercore ISI Outperform
2019-08-12 개시 Guggenheim Buy
2019-08-12 개시 ROTH Capital Buy
2019-08-12 개시 Raymond James Outperform
모두보기

Mirum Pharmaceuticals Inc 주식(MIRM)의 최신 뉴스

pulisher
Jun 04, 2025

Insider Sell: Saira Ramasastry Sells 8,203 Shares of Mirum Pharm - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

Mirum Pharmaceuticals director sells shares totaling $377,843 By Investing.com - Investing.com India

Jun 04, 2025
pulisher
Jun 04, 2025

Mirum Pharmaceuticals director sells shares totaling $377,843 - Investing.com

Jun 04, 2025
pulisher
Jun 03, 2025

(MIRM) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com

Jun 03, 2025
pulisher
May 31, 2025

Mirum pharmaceuticals raises 2025 revenue guidance to $435M-$450M driven by robust growth - MSN

May 31, 2025
pulisher
May 30, 2025

Mirum Pharmaceuticals Holds 2025 Annual Stockholders Meeting - TipRanks

May 30, 2025
pulisher
May 30, 2025

Alagille Syndrome Treatment Market Detailed in New Research ReportMirum Pharmaceuticals, Albireo Pharma - openPR.com

May 30, 2025
pulisher
May 29, 2025

Two Sigma Investments LP Has $5.23 Million Stock Holdings in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - MarketBeat

May 29, 2025
pulisher
May 28, 2025

Man Group plc Invests $289,000 in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - Defense World

May 28, 2025
pulisher
May 26, 2025

Mirum Pharmaceuticals’ SWOT analysis: rare disease stock shows growth potential By Investing.com - Investing.com South Africa

May 26, 2025
pulisher
May 26, 2025

Mirum Pharmaceuticals’ SWOT analysis: rare disease stock shows growth potential - Investing.com Nigeria

May 26, 2025
pulisher
May 26, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Cuts Stock Holdings in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - Defense World

May 26, 2025
pulisher
May 23, 2025

When the Price of (MIRM) Talks, People Listen - news.stocktradersdaily.com

May 23, 2025
pulisher
May 22, 2025

Mirum Pharmaceuticals (MIRM) – Research Analysts’ Weekly Ratings Changes - Defense World

May 22, 2025
pulisher
May 22, 2025

What is HC Wainwright’s Estimate for MIRM Q2 Earnings? - Defense World

May 22, 2025
pulisher
May 20, 2025

Mirum Pharmaceuticals Appoints Doug Sheehy, JD, as Chief Legal Officer - citybiz

May 20, 2025
pulisher
May 20, 2025

Comerica Bank Reduces Stake in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - Defense World

May 20, 2025
pulisher
May 20, 2025

Mirum Pharmaceuticals (NASDAQ:MIRM) Given “Buy” Rating at HC Wainwright - Defense World

May 20, 2025
pulisher
May 19, 2025

Mirum Pharmaceuticals Names Doug Sheehy New Chief Legal Officer - Bloomberg Law News

May 19, 2025
pulisher
May 19, 2025

Mirum Pharmaceuticals (MIRM) Receives Buy Rating from HC Wainwri - GuruFocus

May 19, 2025
pulisher
May 19, 2025

Mirum Pharmaceuticals (MIRM) Appoints New Chief Legal Officer | - GuruFocus

May 19, 2025
pulisher
May 19, 2025

Mirum Pharmaceuticals (MIRM) Receives Buy Rating from HC Wainwright & Co. | MIRM Stock News - GuruFocus

May 19, 2025
pulisher
May 19, 2025

Mirum Pharmaceuticals (MIRM) Receives Buy Rating with Promising Growth Potential | MIRM Stock News - GuruFocus

May 19, 2025
pulisher
May 17, 2025

Analysts Set Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Price Target at $60.64 - Defense World

May 17, 2025
pulisher
May 15, 2025

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Q1 2025 Earnings Call Transcript - MSN

May 15, 2025
pulisher
May 15, 2025

Northern Trust Corp Acquires 32,059 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - Defense World

May 15, 2025
pulisher
May 15, 2025

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Shares Sold by The Manufacturers Life Insurance Company - Defense World

May 15, 2025
pulisher
May 14, 2025

Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences - Business Wire

May 14, 2025
pulisher
May 13, 2025

Mirum Pharmaceuticals (MIRM) Maintains Strong Buy Rating with Ra - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Mirum Pharmaceuticals (MIRM) Gets Price Target Boost to $77 | MI - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Trend Tracker for (MIRM) - news.stocktradersdaily.com

May 13, 2025
pulisher
May 12, 2025

FY2025 EPS Estimates for MIRM Raised by Cantor Fitzgerald - Defense World

May 12, 2025
pulisher
May 12, 2025

Leerink Partnrs Brokers Increase Earnings Estimates for MIRM - Defense World

May 12, 2025
pulisher
May 11, 2025

JMP Securities Increases Mirum Pharmaceuticals (NASDAQ:MIRM) Price Target to $76.00 - Defense World

May 11, 2025
pulisher
May 09, 2025

Mirum Pharmaceuticals (MIRM) Price Target Raised Following Stron - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

May 09, 2025
pulisher
May 09, 2025

Beyond The Numbers: 4 Analysts Discuss Mirum Pharmaceuticals Stock - Benzinga

May 09, 2025
pulisher
May 09, 2025

Mirum Pharmaceuticals (MIRM) Maintains Market Outperform Rating with Higher Price Target | MIRM Stock News - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Mirum's Q1 Earnings Beat Estimates, 2025 Revenue View Raised - MSN

May 09, 2025
pulisher
May 09, 2025

Volixibat Data from Mirum’s VANTAGE PBC Study Showcased at EASL - Business Wire

May 09, 2025
pulisher
May 09, 2025

Mirum Pharmaceuticals First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

May 09, 2025
pulisher
May 09, 2025

JMP raises Mirum Pharmaceuticals stock target to $76 By Investing.com - Investing.com Canada

May 09, 2025
pulisher
May 09, 2025

Mirum Pharmaceuticals (MIRM) Price Target Raised Following Strong Revenue Outlook | MIRM Stock News - GuruFocus

May 09, 2025
pulisher
May 08, 2025

Evercore ISI lifts Mirum stock target to $76, maintains outperform By Investing.com - Investing.com Canada

May 08, 2025
pulisher
May 08, 2025

Evercore ISI lifts Mirum stock target to $76, maintains outperform - Investing.com

May 08, 2025
pulisher
May 08, 2025

Mirum Pharmaceuticals Reports Strong Q1 2025 Results - TipRanks

May 08, 2025
pulisher
May 08, 2025

Earnings call transcript: Mirum Pharmaceuticals beats Q1 2025 revenue forecasts - Investing.com

May 08, 2025
pulisher
May 07, 2025

Mirum Pharmaceuticals beats Q1 estimates, raises 2025 guidance; shares rise - Investing.com Nigeria

May 07, 2025
pulisher
May 07, 2025

Mirum Pharmaceuticals, Inc. (MIRM) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

May 07, 2025

Mirum Pharmaceuticals Inc (MIRM) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$1.15
price up icon 1.30%
$584.68
price up icon 0.75%
$308.75
price up icon 1.19%
$37.33
price up icon 2.30%
$4.68
price down icon 3.35%
$492.00
price up icon 1.78%
자본화:     |  볼륨(24시간):